QTREX Announces Management Share Purchase PlanNes Ziona, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure today announced that Dagi Ben-Noon, Chief Executive Officer of QTREX, Tal Parnas, Chairman of the Company’s Board of Directors, and members of the Company’s senior management team have informed QTREX’s Board of Directors of their intention to use personal funds to purchase up to an aggregate of 2,000,000 of the Company’s ordinary shares, no par value per share (the “Ordinary Shares”) over the next 12 months from June 22, 2026, pursuant to and subject to applicable rules and regulations as well as the Company’s insider trading policy.
Brunswick Corporation Announces Operational Updates at Lowell FacilityChanges will improve efficiency, better use existing space, and support long-term U.S. manufacturing
Robinhood Announces Private Offering of $2.0 Billion of Convertible Senior Notes Due 2029Opportunistic capital raise with proceeds used to enhance strategic flexibility to invest for future growth
GXO to Support Action’s Expansion Across Central and Southern Italy with New Distribution Center in FerentinoNew facility will be powered by GXO’s retail logistics expertise with a commitment to sustainable, efficient operations
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum DisorderSAN FRANCISCO and BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced topline results from IRIS (ML-004-002), a Phase 2 study of ML-004 in autism spectrum disorder (ASD). The study randomized 161 participants (102 adolescents, 59 adults), with prespecified analyses planned by age group and baseline irritability severity.
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of DepressionWILMINGTON, Del., June 22, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biopharmaceutical company that focuses on neuroplastic therapies for depression, PTSD, and related conditions, today announces the approval by FDA of an Intermediate Population Expanded Access Protocol for the use of NRX-101, a fixed dose combination of D-cycloserine (DCS) and lurasidone for the augmentation of accelerated Transcranial Magnetic Stimulation (TMS). Expanded Access Protocols are part of FDA’s compassionate care approach to making investigational drugs available to patients with serious or life-threatening medical conditions1.
Mavenir Launches Agentic Service Assurance Framework to Monitor and Operate the NetworkTM Forum IG1251/IG1453-aligned, multi-agent framework that learns from NOC expertise to deliver scalable, closed-loop automation across multi-vendor, multi-domain networks. AI detects, diagnoses, recommends and resolves network issues faster, improving operator productivity and enabling autonomous network operations.
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with TacrolimusTegoprubart-treated patients maintained higher mean eGFR over time, including a statistically significant approximately 12 mL/min/1.73 m² advantage at month 18 versus tacrolimus (74 vs. 61 mL/min/1.73 m²; p<0.05)
Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing
Fervo Energy Reports First Quarter 2026 ResultsHOUSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Fervo Energy Company (“Fervo” or the “Company”) (
NASDAQ: FRVO), a leading technology-enabled independent power producer of Enhanced Geothermal Systems (EGS), today reported financial and operational results for the first quarter ended March 31, 2026.
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer ScreeningFindings from more than 5,500 plasma samples demonstrate the feasibility of combining deep plasma proteomics generated by the Proteograph Product Suite with ID-Free AI approaches across ten major cancer types
Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and NamodenosonRamat-Gan, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced the publication of a peer-reviewed scientific article demonstrating the broad therapeutic potential of its lead drug candidates, Piclidenoson and Namodenoson, across multiple major diseases.
Sparklight Strengthens Local Communities through More than $125,000 in Charitable Giving Fund GrantsAwards support programs focused on food insecurity, child and senior advocacy, digital literacy, technology access and more
Digital Realty Announces Transactions to Drive Continued Platform GrowthSecures Two-Gigawatt Development Site in Kansas City Metro, and Plans to Increase Teraco Ownership and to Acquire Columbia Capital
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis ProgramResubmission of updated data package to MHRA, expected in 3Q 2026, to enable Phase 2a human influenza Challenge study to proceed
DHT Holdings, Inc. announces the results of the 2026 annual meeting of shareholdersHAMILTON, BERMUDA, June 22, 2026 – DHT Holdings, Inc. (
NYSE:DHT) (“DHT”) announces the results of its 2026 Annual Meeting of Shareholders (the “Annual Meeting”), held on Thursday, June 18, 2026. Shareholders holding an aggregate of 101,497,532 common shares of DHT were present or represented by proxy at the Annual Meeting, representing approximately 63.03% of the issued and outstanding common shares of DHT as of the close of business on April 23, 2026, the record date for the meeting.
ITG, Inc. Announces Launch of Initial Public OfferingFORT LAUDERDALE, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- ITG, Inc. (“ITG” or the “Company”), a leading provider of end-to-end services to the communications and digital infrastructure industries, today announced that it has launched the roadshow for the proposed initial public offering of its Class A common stock. The Company is offering 19,512,196 shares of its Class A common stock. In addition, the Company and the selling stockholder identified in the registration statement filed with the United States Securities and Exchange Commission (the “SEC”) intend to grant the underwriters a 30-day option to purchase up to an additional 2,168,635 shares and 758,194 shares of Class A common stock from the Company and the selling stockholder, respectively, at the initial public offering price, less underwriting discounts and commissions.
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAMaranello (Italy), June 22, 2026 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 250 million share buyback program announced on April 10, 2026, as the second tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the “Second Tranche”), the additional common shares - reported in aggregate form, on a daily basis on the Euronext Milan (EXM) and on the New York Stock Exchange (NYSE) as follows:
Fervo Energy and PNNL Leverage AI and NVIDIA Accelerated Computing for New Digital Twin Platform Designed to Advance Geothermal DevelopmentNew platform will integrate real-time field data, physics-based modeling, and AI to advance critical geothermal infrastructure and maximize power generation
Cyber Acoustics Introduces ACCESS AI Workforce Verification Platform Alongside Next-Generation Headsets for Call CentersTechnology Showcase at CCW in Las Vegas will preview ACCESS AI workforce verification software to help BPOs improve operational oversight
WeRide, Geely Farizon and Kwoon Chung Launch Right-Hand-Drive Robotaxis at the 2026 International Automotive & Supply Chain Expo (Hong Kong), Accelerating Global ExpansionHONG KONG, June 22, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, today announced the joint development of Robotaxis specifically designed for right-hand-drive markets, as part of a strategic partnership with Geely Farizon New Energy Commercial Vehicle Group (Geely Farizon), China’s top new energy commercial vehicle brand, and Kwoon Chung Bus Holdings Limited, a leading public transport operator in Hong Kong at the 2026 International Automotive & Supply Chain Expo (Hong Kong).
Equinox Gold Publishes 2025 Sustainability ReportVANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (“Equinox Gold” or the “Company”) is pleased to announce the publication of its 2025 Sustainability Report. Aligned with the Global Reporting Initiative (GRI) and Sustainability Accounting Standards Board (SASB) frameworks, the report provides an overview of the Company’s performance and progress across key environmental, social and governance topics, including safety, environmental stewardship, community engagement and ethical business practices. The report covers the period from January 1 to December 31, 2025, with certain reporting scope considerations reflecting the Company’s June 2025 combination with Calibre Mining and other portfolio changes during the year. The report, together with detailed GRI and SASB data tables, is available for review and download on Equinox Gold’s website at www.equinoxgold.com/responsible-mining.
BidMachine Introduces Direct Placements and Agentic ReadinessTrust-grade Mobile Supply program scaled to 20 plus active demand partners; Protocol agnostic Agentic Readiness interface opens to buyer-agent test partners ahead of Q3 2026 launch
FORTESCUE AND CMB.TECH SIGN MILESTONE AGREEMENT FOR 12 AMMONIA BULKERS TO ACCELERATE ZERO-EMISSIONS SHIPPINGAntwerp, June 22, 2026 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) and Fortescue have signed a milestone agreement for the charter of up to 12 ammonia-capable vessels, marking a significant step towards decarbonising global shipping and advancing the adoption of ammonia as a shipping fuel.
STMicroelectronics unveils new compact direct Time-of-Flight 3D LiDAR module bringing high-resolution spatial awareness to compact edge AI systems with industry-leading resolution and performanceSTMicroelectronics unveils new compact direct Time-of-Flight 3D LiDAR module bringing high-resolution spatial awareness to compact edge AI systems with industry-leading resolution and performance
Pacvue Launches Pacvue Prism, Powering the Industry's First Agentic Commerce GridPacvue Prism expands existing and recently announced integrations including ChatGPT, The Trade Desk, and adds new integrations with Pinterest, tvScientific by Pinterest, Firework, and Shopsense AI for alpha launch; Additional integrations are underway, most notably Yahoo DSP, to connect and power the industry’s first Agentic Commerce Grid
Samba Acquires Bestever AI to Accelerate the Future of Agentic AdvertisingSAN FRANCISCO, June 22, 2026 (GLOBE NEWSWIRE) -- Samba, the global leader in media intelligence, today announced the acquisition of Bestever AI, a GenAI platform built for advertisers and marketers. Bestever founder and CEO Apoorva Govind joins Samba as Director of Product, leading the company's AI product strategy, along with the full Bestever team.
SKG Brings Deep Recovery Technology to Father’s Day GiftingNEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- This Father’s Day, SKG is bringing smart recovery to the top of the gift list with wearable smart massagers designed for dads’ everyday routines. As thoughtful gift options, SKG G7 Pro Fold 3.0 Neck Massager and W9 Ultra 2.0 Lower Back Massager offer targeted comfort for dads who spend long hours at a desk, commute frequently, train regularly, or keep showing up for the people who count on them.
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026Geneva, Switzerland, June 22, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will report its First Quarter 2026 Financial Results on June 25, 2026. Tim Dyer, CEO and Mikhail Kalinichev, Head of Translational Science, will provide a business update and review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) on June 25, 2026.
Getty Images Announces Display Partnership with OpenAIMulti-year agreement brings Getty Images’ licensed content into OpenAI search and discovery experiences in ChatGPT
Abaxx Continues to Provide Facts Refuting Ongoing Misinformation and Reaffirms Strong Business FundamentalsTORONTO, June 21, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (TSX:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today provided additional facts refuting ongoing misinformation published about the Company by Viceroy Research Group (“Viceroy”).
Global Nexa Initiative Launches to Support Climate and Health InnovationsGlobal consortium seeks bold, scalable solutions that reduce climate-driven health harms on vulnerable communities
Walk to Earn? AIXAlpha Launches a New Daily Investment Program That Feels Just as SimpleThe phrase “Walk to Earn?” has been trending across social platforms—not because people believe walking literally generates income, but because it reflects a broader desire for financial participation that feels simple, intuitive, and effortless.
This Father's Day, Healthy Moms, Healthy Babies America Calls on Fathers to Help End America's Maternal Health CrisisNational campaign includes open letter with Elaine Welteroth and Charles Johnson, a forthcoming bipartisan op-ed from Senators Cory Booker and John Boozman, essays from faith leaders, and CNN conversation on the role fathers play in safer births
RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regencell To Contact Him Directly To Discuss Their Options
Constantino Closes NY-21 Primary Explaining How He Will Bring Back American ManufacturingROME, N.Y., June 20, 2026 (GLOBE NEWSWIRE) -- Trump endorsed NY-21 candidate, Anthony Constantino, closed the NY-21 primary holding an event at the Capitol Theater in Rome, NY dubbed ‘Made In America Again.’ The Sticker Mule CEO explained how he personally ripped products out of Asia and South America, bringing them back to America, driving huge job creation in his community, and driving forward the American economy. He further explained how he will help companies all across America restore jobs and industry from overseas from his seat in Congress.
CKYN LLC Launches The Complete CKYN Protocol, a Three-Step Copper Peptide Skincare System Made in the USAKirkland, WA, June 20, 2026 (GLOBE NEWSWIRE) -- CKYN LLC today announced the launch of The Complete CKYN Protocol, a three-step skincare system built around GHK-Cu (Copper Tripeptide-1). Unlike most prestige skincare brands, which formulate with twenty or more ingredients, CKYN's entire system is built on six primary bioactives, each chosen for its place in published cosmetic science research and formulated at concentrations designed to produce visible change.
PICS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds PicS N.V. (PICS) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PicS To Contact Him Directly To Discuss Their Options
PHR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their Options
GRAL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Grail To Contact Him Directly To Discuss Their Options
GPK UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Graphic Packaging (GPK) Investors of Securities Class Action Lawsuit Deadline on July 6, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Graphic Packaging To Contact Him Directly To Discuss Their Options
ERAS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their Options
GLOB UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Globant S.A. (GLOB) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Globant To Contact Him Directly To Discuss Their Options
FSK UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds FS KKR Capital (FSK) Investors of Securities Class Action Lawsuit Deadline on July 3, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FS KKR Capital To Contact Him Directly To Discuss Their Options
POET UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds POET Technologies (POET) Investors of Securities Class Action Lawsuit Deadline on June 29, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In POET Technologies To Contact Him Directly To Discuss Their Options
SES UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds SES AI Corporation (SES) Investors of Securities Class Action Lawsuit Deadline on June 26, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SES AI To Contact Him Directly To Discuss Their Options
Bunker Hill Mining Announces Director ResignationKELLOGG, Idaho and VANCOUVER, British Columbia, June 19, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is announcing that Mr. Mark Child has resigned from the Board of Directors of the Company, effective immediately.
The Market Leaves Clues; Eagle Eye Was Built to See Them — in Real TimeNew investor signal-intelligence platform reads social, forum, and news chatter across thousands of conversations — and surfaces the tickers the crowd is piling into, with the sentiment and catalysts behind them. Free to start.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (
NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on June 18, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 140,860 shares of Iovance’s common stock to twenty-seven new, non-executive employees.
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2026LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2026
Weatherford Announces Second-Quarter 2026 Conference CallHOUSTON, June 19, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (
NASDAQ: WFRD) (“Weatherford” or the “Company”) will host a conference call on Wednesday, July 22, 2026 to discuss the Company’s results for the second quarter ended June 30, 2026.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44,409 restricted stock units of the company’s common stock to 15 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of June 16, 2026, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)CAMBRIDGE, Mass., June 19, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on June 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 39,000 shares of the Company’s common stock to three newly hired employees of the Company, each as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grants”).
BTC/USD Volatility Creates Fast-Moving Opportunities; AIXAlpha Launches Automated BTC Strategy ContractsAI‑Powered Automated BTC Strategy Contracts help users capture volatility‑driven opportunities instantly—no installation, no manual trading, no experience required.
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Certara (CERT) To Contact Him Directly To Discuss Their Options
POET DEADLINE ALERT: POET Technologies, Inc. Investors Have Until June 29th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff RoleBragar Eagel & Squire, P.C. Litigation Partner��Brandon Walker Encourages Investors Who Suffered Losses In POET To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. is Investigating Hub Group, Inc. on Behalf of Hub Group Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hub Group (HUBG) To Contact Him Directly To Discuss Their Options
